← Open Payments lookup

ANIKA VAUGHN-COOKE: Open Payments

NPI 1376779470 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,019 in 78 payments from 12 companies in 2025. Trend: 2023 $903 · 2024 $1,147 · 2025 $2,019

Food & beverage: $1,920Education: $99
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc13$384
Neurocrine BioSciences, Inc.11$358
Teva Pharmaceuticals USA, Inc.11$322
ABBVIE INC.12$247
Alkermes, Inc.8$186
E.R. Squibb & Sons, L.L.C.6$143
Otsuka America Pharmaceutical, Inc.6$115
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$109
Vanda Pharmaceuticals Inc.2$62
Lundbeck LLC2$47

Products named: INVEGA SUSTENNA, INGREZZA, VRAYLAR, UZEDY, ARISTADA, REXULTI, COBENFY, CAPLYTA.

Industry payments across PA — which companies pay providers there.